Robotic-assisted minimally invasive multivessel coronary artery surgery: a propensity-matched analysis Authors: Arzum Kale, Ulusal Coşkun, Alizamin Yusifli, Makbule Kesici, Yılmaz Deniz, Hilmi Ahmet Subaşı, Mehmet Fatih Ayık, Suat Buket Published: 2026 ABSTRACT AbstractBackgroundRobotic-assisted CABG is a minimally invasive alternative to conventional sternotomy. The purpose of this study was to evaluate the short and mid-term outcomes of our experience and to enrich the literature with quality comparisons of these procedures.MethodsFrom 1 October, 2020 to 1 July, 2025, 927 CABG procedures were performed at a single institution. Two groups of patients were analyzed: the robotic assisted minimally invasive CABG group (RA-CABG) and the conventional sternotomy CABG group (CS-CABG). This was a retrospective comparison of all consecutive patients undergoing conventional CABG and RA-CABG with the use of propensity score matching with 24 preoperative covariates. Of the 927 cases, 480 patients were matched with 240 patients each in the RA-CABG and CS-CABG groups.ResultsThe matching successfully eliminated all preoperative differences between the groups. There were three conversions to median sternotomy in the robotic group. Number of distal anastamoses per patient was 2.84 in the RA-CABG group and was 3.05 in the CS-CABG group. The cross clamp time and cardiopulmonary bypass time were statistically significantly shorter in the CS-CABG group (cross clamp: 59 vs. 47, minutes and CPB: 95 vs. 67, minutes, p = 0.001). The RA-CABG group had significantly (p < 0.001) lower 24-h postoperative blood loss (400 ml vs. 800 ml), fewer blood transfusion, shorter mechanical ventilation time (6 vs. 10, hours), shorter length of ICU stay (20 vs. 28, hours), shorter length of hospital stay (6 vs. 7, days). Early mortality (in-hospital and operative) rates were similar between the groups, 0.8% for RA-CABG and 1.3% for CS-CABG (p = 0.683). In like manner, there was no significant difference in mid-term mortality rates between the two groups (p = 0.258).ConclusionsThe RA-CABG is safe and feasible alternative to the conventional sternotomy CABG. This method offers advantages such as avoiding sternotomy, providing greater comfort to the surgeon during LIMA harvesting, and enabling longer LIMA harvesting.Keywords: Minimally invasive direct coronary artery surgery, Robotic cardiac surgery, Coronary artery revascularization, Multivessel coronary artery bypass grafting, Robotic-assisted LIMA harvesting Introduction Coronary artery bypass grafting (CABG) surgery remains one of the most critical treatment methods for coronary artery disease [1, 2]. Advances in surgical devices and techniques have led to a transition from traditional open-wound surgeries toward minimally invasive and robotic-assisted procedures, which aim to reduce invasiveness while maintaining the durability of surgical revascularization. While minimally invasive techniques were initially intended for isolated lesions, technological developments and increased surgical experience now allow for the treatment of multivessel disease [3–7]. Specifically, robot-assisted minimally invasive CABG (RA-MIDCAB) combines robotic-assisted LIMA harvesting with a thoracotomy approach, offering the advantages of both precision robotics and minimal invasiveness. According to the European Society of Cardiology (ESC) guidelines, the on-pump strategy is considered the gold standard in coronary revascularization [8]. The modern renewal of the on-pump strategy—regardless of the surgical approach used—enables surgeons to achieve complete revascularization through a thoracotomy just as they would through a traditional sternotomy. With patent LIMA-LAD anastomosis, achieving complete revascularization is the primary determinant of long-term survival and reduction in cardiac events [9, 10]; therefore, this goal should not be compromised for the sake of a minimally invasive approach. If complete revascularization can be achieved using a minimally invasive method, as well as the standard method, then the minimally invasive method should be preferred. Robotic assistance can be used in minimally invasive coronary artery bypass grafting (MICS CABG). Robotic technology offers advanced dexterity, visualization, and instrument movement capabilities that enable better outcomes [11]. In technical terms, robotic CABG could be classified as totally endoscopic or robot-assisted minimallyinvasive, depending on the way the grafts are anastomosed to the native arteries. If it is to be used only for LIMA graft harvesting, this method is called robot-assisted minimally invasive coronary artery bypass grafting (RA-MIDCAB); if robotic assistance is also used for anastomoses, it is called the totally endoscopic coronary artery bypass (TECAB) surgery method. Robot-assisted minimally invasive CABG is a combination of two techniques that offers the advantages of both robotic assistance and minimally invasive techniques in coronary bypass surgery. This study compares multivessel CABG performed through left thoracotomy with robotic-assisted LIMA harvesting to the standard sternotomy approach. With the renewed importance of the on-pump strategy enabling equivalent revascularization regardless of incision, the central hypothesis is that both techniques can achieve the same extent of revascularization and yield comparable clinical outcomes; accordingly, the study evaluates whether minimally invasive robotic-assisted CABG provides efficacy and safety similar to those of the traditional sternotomy approach. Study design and patient selection A retrospective review of all cases that underwent isolated coronary artery bypass surgery at our institution between 2020 and 2025 was conducted. Redo cases and emergency cases were excluded from the study. All cases included in this single-center study were performed by a single surgical team. The learning curve was included. Two groups of patients were selected: the robotic assisted minimally invasive CABG group (RA-CABG) and the conventional sternotomy CABG group (CS-CABG). Preoperative patient demographics, perioperative and postoperative data of the patients were retrospectively extracted from hospital records and analysed. Although on-pump multi-vessel cases constitute the majority, off-pump single-vessel cases are also present in both groups. In both the robotic and sternotomy groups, all single-vessel CABG surgeries were performed off-pump, while all remaining CABG surgeries in both groups were performed using CPB. In RA-CABG group, preoperative computed tomography angiography (CTA) was performed for all patients and all cases were performed with Da Vinci Robotic Systems. Since 2020, we have done 927 CABG procedures, of which 681 were CS-CABGs and 246 were robotically assisted CABG procedures. Of the 927 cases, 480 patients were matched with 240 patients each in the RA-CABG and CS-CABG groups. Propensity score matching was performed with the use of 24 preoperative covariates for a fair comparison (Fig. 1). The matching considered sex, age, BMI, family history, diabetes mellitus, hypertension, smoking status, renal failure, dyslipidemia, presence of chronic atrial fibrillation, carotid disease (radiologically proven), peripheral vascular disease (radiologically proven), chronic obstructive pulmonary disease, history of stroke, Canadian Cardiovascular Society (CCS) angina class, New York Heart Association (NYHA) dyspnea class, history of infarction, history of percutaneous intervention, left-ventricular ejection fraction, number of affected coronary arteries, need of intravenous nitrates preoperatively, aspirin intake, intake of other antiagregants, and urgency of surgery. Mirror histograms (A) before propensity score matching and (B) after propensity score matching Surgical technique CS-CABG Conventional CABG was performed by midline sternotomy incision. Both group involved CPB and cardioplegic arrest in most cases, with endoscopic harvesting of the saphenous vein or radial artery for grafting, in addition to the left internal mammary artery. RA-CABG All patients were prepared in the supine position with their left chest elevated approximately 30 degrees. After routine induction of general anesthesia, a double-lumen intubation was performed for single right lung ventilation, right internal jugular venous line was inserted, and a transesophageal echocardiography (TEE) probe was positioned. Our surgical technique has been described previously [12]. The surgery started with an introduction of three 8-mm trocars in the anterior axillary line in the second, fourth, and sixth or seventh intercostal space and the da Vinci Xi robot system (Intuitive Surgical, Inc., Sunnyvale, CA, USA) was docked. A camera and 2 lateral arms with surgical instruments were introduced into the left pleural cavity and CO2 insufflation between 8 and 12 mm Hg was used. The robot was then used to harvest the LIMA in a semiskeletonized fashion. The robotic small clip applier, cautery spatula, and microbipolar forceps were the instruments used. Heparin was administered to achieve an activated clotting time > 300 s, and the LIMA was divided distally between clips. The robot was then undocked. Axillary or mostly femoral cannulation was planned according to preoperative CTA findings, and was performed under TEE guidance. A small (6–7 cm) left anterior incision was made at the third or fourth intercostal space. The antegrade cardioplegia needle/vent was placed in the ascending aorta, and the Chitwood clamp was passed through the thorax wall in the second or third intercostal space and positioned around the aorta allowing the aortic clamping. All anastomoses were performed by hand suturing, either with or without cardiopulmonary bypass. After the completion of the distal anastomoses, the cross clamp was removed and a side-biting clamp was placed on the aorta to perform the proximal anastomoses. The radial artery (for left coronary system) and the saphenous vein (for right coronary artery) were used as an additional graft in case of need. The additional grafts were endoscopically harvested. In most cases, proximal anastomoses of the radial artery graft were performed onto the LIMA. Statistical analysis The data were analyzed using the IBM SPSS Statistics Standard Concurrent User V 27 statistical package program (IBM Corp., Armonk, New York, USA). Descriptive statistics were presented as the number of units (n), percentage (%), mean ± standard deviation, and median (min-max) values. Since the data did not show a normal distribution in the analysis results, the values were given as median (IQR). The normal distribution of the data for numerical variables was evaluated using the Shapiro Wilk normality test, and the homogeneity of variances was evaluated using the Levene test. Since the prerequisites for parametric tests were not met when comparing the two groups, the Mann Whitney U Test was used. The Chi-Square test was used to compare categorical variables between groups. For the evaluation of time-to-event data, Kaplan-Meier analysis was used to construct survival curves. A p-value < 0.05 was considered statistically significant. Propensity Score Matching analyses were performed using the MatchIt package in R Version 4.5.2. The Kaplan-Meier graph was created using the Survival and Survminer packages. Results CABG surgeries performed consecutively at our hospital since October 2020 are shown in Fig. 2. Throughout the study period, 681 patients underwent conventional sternotomy CABG and 246 patients underwent robotic-assisted minimally invasive CABG. Using the propensity-score matching, 240 pairs were found and compared. The matching successfully eliminated all preoperative differences between the groups. The preoperative characteristics of the patients are presented in Table 1. Single-vessel patients in both groups (in the RA-CABG group 17 (7.1%) and in the CS-CABG group 14 (5.8%)) underwent off-pump surgery. Due to prohibiting findings in the iliac vessels and aorta, axillary cannulation was performed in 7 (2.9%) patients in the RA-CABG group, while femoral artery cannulation was performed in the remaining patients. In the CS-CABG group, all patients underwent central cannulation. In the RA-CABG group, based on CTA measurements, the left thoracotomy was performed through the 4th ICS in 183 patients (76.3%), through the 3rd ICS in 57 (23.7%) patients. There were three conversions to median sternotomy in the robotic group. The reasons for conversion were insufficient LIMA flow in first, intraoperatively myocardial infarction in second patient, and pulmonary artery injury in third. Except for these two patients, in all patients in both groups the left internal mammary artery was anastomosed to the LAD. Radial artery was preferred in young patients and left sided vessel anastomoses. All target coronary arteries with a bypass indication were effectively revascularised and complete revascularization was achieved in both groups. The number of distal anastomoses per patient was 2.84 in the RA-CABG group, while it was 3.05 in the CS-CABG group, which is not a statistically significant difference (p = 0.063). The cross clamp time and cardiopulmonary bypass time were statistically significantly shorter in the CS-CABG group (cross clamp: 59 vs. 47, minutes and CPB: 95 vs. 67, minutes, p = 0.001). We believe that the inclusion of the learning curve in the RA-CABG group was effective in this result. The operative data are presented in Table 2. The median follow-up was 29 months in CS-CABG group (up to 61 months), and 28 months in RA-CABG group (up to 59 months). The RA-CABG group had significantly (p < 0.001) lower 24-h postoperative blood loss (400 ml vs. 800 ml), fewer blood transfusion, shorter mechanical ventilation time (6 vs. 10, hours), shorter length of ICU stay (20 vs. 28, hours), shorter length of hospital stay (6 vs. 7, days). Fewer RA-CABG patients required prolonged postoperative ventilation (> 24 h) (1.3% vs. 6.6%, p = 0.004). When we examine Table 3, we see that postoperatively new onset of AF (7.9% vs. 16.7%), pulmonary complications (6.3% vs. 15.8%), wound healing complications (0.8% vs. 7.5%) are significantly (p < 0.001) more in the CS-CABG group compared with the RA-CABG group. Incidence of postoperative renal failure requiring dialysis was lower in the RA-CABG group (1.3%) vs. the CS-CABG group (3.4%, p = 0.024). Early mortality (in-hospital and operative) rates were similar between the groups. In like manner, there was no significant difference in reoperation for bleeding, need of IABP, postoperative stroke, postoperative MI, late PCI and late mortality (> 30 days) rates between the two groups. When both groups were examined in terms of reoperation due to bleeding, no statistically significant difference was found (p = 0.598). However, in the sternotomy group, 7 of the patients who underwent reoperation due to bleeding had bleeding from the LIMA bed, while the rest originated from other surgical areas such as the proximal and distal anastomoses and sternotomy. In the robotic group, 6 of the patients who underwent reoperation due to bleeding had bleeding from the LIMA bed, while the rest originated from other surgical areas such as the proximal and distal anastomoses. Our early mortality rates were 0.8% for RA-CABG and 1.3% for CS-CABG (p = 0.683). These patients were lost after developing low cardiac output due to perioperative myocardial infarction. Furthermore, one of these patients in the RA group underwent veno-arterial ECMO placement. Late mortality was observed in 2 (0.8%) patients in the RA group, and in 5 (2.1%) patients in the CS group. One of those patients in the RA group was lost due to pulmonary emboli and the other one was lost due to malignancy. In the CS group, one of these patients was lost due to cardiac arrest, two of them were lost due to malignancy, and the other two patients were lost for unknown reasons. 7 (3.0%) patients in the RA group, and 10 (4.3%) patients in the CS group underwent late coronary reintervention. None of these patients were reoperated; all of them were revascularised with PCI. Additionally, when comparing readmissions within the first 30 days, we observe that this rate is significantly lower in the RA group (5.4% vs. 12.1%, p = 0.010). The estimated survival according to Kaplan-Meier analysis was 97.9% (CI 95.0–99.0%) at 5 years postoperatively in the RA-CABG group. For the CS-CABG group it was 93.5% (CI 89.2–98.0%) at 5 years (Fig. 3). Trends in the use of conventional and robotic-assisted coronary artery bypass grafting between October 2020 and July 2025 at our institution Table 1Preoperative characteristics of patientsRA-CABG(n = 240)CS-CABG(n = 240)p-valueElective, n (%)221 (92.1)224 (93.3)0.598Urgent, n (%)19 (7.9)16 (6.7)0.598Age (years), median (IQR)62 (53.77)63 (54.77)0.160Sex, n (%) Male Female199 (82.9)41 (17.1)202 (84.2)38 (15.8)0.712BMI (kg/m2), median (IQR)28.7 (25.6, 31.8)28.9 (25.8, 32.0)0.116Family history, n (%)50 (20.8)43 (17.9)0.419CCS Class, n (%) I II III IV72 (30.1)153 (64.0)15 (6.0)0 (0.0)74 (31.0)146 (61.0)20 (8.3)0 (0.0)0.622NYHA Class, n (%) I II III IV193 (80.4)36 (15.0)11 (4.6)0 (0.0)195 (81.3)30 (12.5)15 (6.2)0 (0.0)0.557HT, n (%)162 (67.5)169 (70.4)0.490Dyslipidemia, n (%)134 (55.8)128 (53.3)0.582COPD, n (%)14 (5.8)17 (7.1)0.577Smoking status, n (%) Smoker Ex smoker Non smoker84 (35.0)73 (30.4)83 (34.6)86 (35.8)83 (34.6)71 (29.6)0.831DM, n (%) Insulin OAD Diet25 (28.1)42 (47.2)22 (24.7)23 (23.5)51 (52.0)24 (24.5)0.737Renal failure, n (%)9 (3.8)16 (6.7)0.150Carotid disease, n (%)14 (5.8)28 (11.7)0.124PVD, n (%)16 (6.7)13 (5.4)0.565Chronic atrial fibrillation, n (%)8 (3.3)3 (1.2)0.118EuroSCORE II (%), median (IQR)1.41 (0.70, 2.11)1.62 (0.81, 2.43)0.105History of Stroke, n (%)14 (5.8)12 (5.0)0.687History of MI, n (%)48 (20.0)49 (20.4)0.910History of PCI, n (%)67 (27.9)65 (27.1)0.838LVEF (%), median (IQR)60 (50.6)60 (49.4)0.512Coronary Disease, n (%)1-vessel disease2-vessel disease3-vessel disease>3-vessel disease17 (7.1)73 (30.4)89 (37.1)61 (25.4)14 (5.8)64 (26.7)83 (34.6)79 (32.9)0.701Intravenous nitrat preop, n (%)20 (8.3)28 (11.7)0.224Medication-Aspirin take, n (%)200 (83.3)197 (82.1)0.717Medication-other antiagregants take, n (%)71 (29.6)78 (32.5)0.490The table shows n (%) values for categorical data and median (interquartile range) values for continuous data. The Chi-Square test was used to analyze categorical data, and the Mann Whitney U test was used to analyze continuous data. IQR, interquartile range; BMI, body mass index; CCS, Canadian Cardiovascular Society angina classification; NYHA, New York Heart Association dyspnea classification; HT, hypertension; COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus; OAD, oral antidiabetic drugs; Renal failure, patient on dialysis or chronic kidney disease stage 3 or higher; Carotid disease, radiologically proven significant stenosis of corresponding vessels; PVD, peripheral vascular disease- radiologically proven severe stenosis of limb arteries; EuroSCORE II, risk prediction model for 30 day post-operative mortality; MI, myocardial infarction; PCI, percutaneous coronary intervention; LVEF, left-ventricular ejection fraction; Preop, preoperatively; Urgent surgery, non-elective state when the patient had to be operated within one admission for medical reasons. Bold values highlight statistically significant differences according to p-values Preoperative characteristics of patients Sex, n (%) Male Female 199 (82.9) 41 (17.1) 202 (84.2) 38 (15.8) CCS Class, n (%) I II III IV 72 (30.1) 153 (64.0) 15 (6.0) 0 (0.0) 74 (31.0) 146 (61.0) 20 (8.3) 0 (0.0) NYHA Class, n (%) I II III IV 193 (80.4) 36 (15.0) 11 (4.6) 0 (0.0) 195 (81.3) 30 (12.5) 15 (6.2) 0 (0.0) Smoking status, n (%) Smoker Ex smoker Non smoker 84 (35.0) 73 (30.4) 83 (34.6) 86 (35.8) 83 (34.6) 71 (29.6) DM, n (%) Insulin OAD Diet 25 (28.1) 42 (47.2) 22 (24.7) 23 (23.5) 51 (52.0) 24 (24.5) Coronary Disease, n (%) 1-vessel disease 2-vessel disease 3-vessel disease >3-vessel disease 17 (7.1) 73 (30.4) 89 (37.1) 61 (25.4) 14 (5.8) 64 (26.7) 83 (34.6) 79 (32.9) The table shows n (%) values for categorical data and median (interquartile range) values for continuous data. The Chi-Square test was used to analyze categorical data, and the Mann Whitney U test was used to analyze continuous data. IQR, interquartile range; BMI, body mass index; CCS, Canadian Cardiovascular Society angina classification; NYHA, New York Heart Association dyspnea classification; HT, hypertension; COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus; OAD, oral antidiabetic drugs; Renal failure, patient on dialysis or chronic kidney disease stage 3 or higher; Carotid disease, radiologically proven significant stenosis of corresponding vessels; PVD, peripheral vascular disease- radiologically proven severe stenosis of limb arteries; EuroSCORE II, risk prediction model for 30 day post-operative mortality; MI, myocardial infarction; PCI, percutaneous coronary intervention; LVEF, left-ventricular ejection fraction; Preop, preoperatively; Urgent surgery, non-elective state when the patient had to be operated within one admission for medical reasons. Bold values highlight statistically significant differences according to p-values Table 2Perioperative data of patientsRA-CABG(n = 240)CS-CABG(n = 240)p-valueConversion to sternotomy, n (%)3 (1.3)--Cross clamp time (min),median (IQR)59 (25)47 (20) 0.001 CPB time (min), median (IQR)95 (35.75)67 (20) 0.001 Axillary cannulation, n (%)7 (2.9)--Off pump cases, n (%)17 (7.1)14 (5.8)0.0913. ICS, n (%)57 (23.7)--4. ICS, n (%)183 (76.3)--Operation, n (%) CABGx1 CABGx2 CABGx3 CABGx4 CABGx517 (7.1)73 (30.4)89 (37.1)52 (21.6)9 (3.8)14 (5.8)64 (26.7)83 (34.6)60 (25.0)19 (7.9)0.701Usage of radial artery graft, n (%)177 (73.8)175 (72.9)0.836Number of distal anastomoses, n (%) 1 2 3 4 5 6 717 (7.1)73 (30.4)89 (37.1)52 (21.6)9 (3.8)0 (0.0)0 (0.0)14 (5.8)64 (26.7)83 (34.6)60 (25.0)14 (5.8)4 (1.7)1 (0.4)0.118Average of distal anastomoses, n2.843.050.063The table shows n (%) values for categorical data and median (interquartile range) values for continuous data. The Chi-Square test was used to analyze categorical data, and the Mann Whitney U test was used to analyze continuous data. IQR, interquartile range; CPB, cardiopulmonary bypass; ICS, intercostal space; CABG, coronary artery bypass grafting Perioperative data of patients Operation, n (%) CABGx1 CABGx2 CABGx3 CABGx4 CABGx5 17 (7.1) 73 (30.4) 89 (37.1) 52 (21.6) 9 (3.8) 14 (5.8) 64 (26.7) 83 (34.6) 60 (25.0) 19 (7.9) Number of distal anastomoses, n (%) 1 2 3 4 5 6 7 17 (7.1) 73 (30.4) 89 (37.1) 52 (21.6) 9 (3.8) 0 (0.0) 0 (0.0) 14 (5.8) 64 (26.7) 83 (34.6) 60 (25.0) 14 (5.8) 4 (1.7) 1 (0.4) The table shows n (%) values for categorical data and median (interquartile range) values for continuous data. The Chi-Square test was used to analyze categorical data, and the Mann Whitney U test was used to analyze continuous data. IQR, interquartile range; CPB, cardiopulmonary bypass; ICS, intercostal space; CABG, coronary artery bypass grafting Table 3Postoperative details of patientsRA-CABG(n = 240)CS-CABG(n = 240)p-value Length of ICU stay (hours), median (IQR) 20 (6.4)28 (12.1)< 0.001Mechanical ventilation time (hours),median (IQR)6 (4)10 (5) < 0.001 Prolonged ventilation (> 24 h), n (%)3 (1.3)15 (6.6) 0.004 Early mortality, n (%)2 (0.8)3 (1.3)0.683Length of hospital stay (days), median (IQR)6 (2)7 (3) < 0.001 Postoperatively new onset of AF, n (%)19 (7.9)40 (16.7) < 0.001 Postoperative MI, n (%)2 (1.3)3 (2.1)0.683Need of ECMO, n (%)1 (0.4)0 (0.0)0.317Need of IABP, n (%)3 (1.3)3 (1.3)0.999Blood loss in first 24 h (ml), median (IQR)400 (250)800 (262.5) < 0.001 Reoperation for bleeding, n (%)19 (7.9)16 (6.7)0.598Pulmonary complication, n (%)15 (6.3)38 (15.8) < 0.001 Renal failure requiring dialysis, n (%)3 (1.3)8 (3.4) 0.024 Postoperative stroke, n (%)4 (1.7)6 (2.5)0.142Need of blood transfusion (units), n (%)180 (77.6)231 (99.1) < 0.001 Wound healing complication, n (%)2 (0.8)18 (7.5) < 0.001 Late mortality, n (%)2 (0.8)5 (2.1)0.258Late PCI, n (%)7 (3.0)10 (4.3)0.470Hospital readmission in the 30 days, n (%)13 (5.4)29 (12.1) 0.010 The table shows n (%) values for categorical data and median (interquartile range) values for continuous data. The Chi-Square test was used to analyze categorical data, and the Mann Whitney U test was used to analyze continuous data. IQR, interquartile range; ICU, intensive care unit; AF, atrial fibrillation; MI, myocardial infarction; ECMO, extracorporeal membrane oxygenation; IABP, intra-aortic balloon pump; PCI, percutaneous coronary intervention; Pulmonary complication, Pulmonary complications, include pleural effusion (presence of at least 300 ml of fluid in the pleural cavity according to postoperative sonography), pneumothorax, subcutaneous emphysema, respiratory infection, and oxygenation disfunction (hypoxemia in arterial blood gas test post-operatively); Early mortality, includes in-hospital mortality and covers the first 30 days postoperatively; Late mortality, covers the period after the 30th postoperative day Postoperative details of patients Mechanical ventilation time (hours), median (IQR) The table shows n (%) values for categorical data and median (interquartile range) values for continuous data. The Chi-Square test was used to analyze categorical data, and the Mann Whitney U test was used to analyze continuous data. IQR, interquartile range; ICU, intensive care unit; AF, atrial fibrillation; MI, myocardial infarction; ECMO, extracorporeal membrane oxygenation; IABP, intra-aortic balloon pump; PCI, percutaneous coronary intervention; Pulmonary complication, Pulmonary complications, include pleural effusion (presence of at least 300 ml of fluid in the pleural cavity according to postoperative sonography), pneumothorax, subcutaneous emphysema, respiratory infection, and oxygenation disfunction (hypoxemia in arterial blood gas test post-operatively); Early mortality, includes in-hospital mortality and covers the first 30 days postoperatively; Late mortality, covers the period after the 30th postoperative day Kaplan-Meier survival analysis of the conventional and robotic CABG groups Discussion Robotic cardiac surgery, which was launched with great excitement in the early 2000s, failed to deliver the expected progress in subsequent years, and the number of cases did not increase sufficiently [13]. Among the main reasons were immature technology, long learning curves, complexity of the procedures as compared to purely videoscopic or direct vision alternatives, and significant cost. With significant advances in surgical robotic technology, an increase in robotic cardiac surgery and the number of participating centers has been observed since 2015 [13]. The technical development of robotic surgery now provides excellent three-dimensional visualization together with enhanced dexterity of robotic arms, being able to perform whole spectrum of procedures: LIMA harvest and total robotic revascularization, complex mitral and tricuspid valve surgery, cardiac tumor resections and others [14]. Robotic-assisted cardiovascular surgeries, which combines the advantages of two revascularization modalities such as the robotic technology and the minimally invasive technique, provide smaller wounds, less rib retraction, less postoperative pain, faster return to normal activities and a positive impact on quality of life [15, 16]. When we examine the literature, we can see that the majority of robotic-assisted coronary revascularization publications include single-vessel bypass cases. This situation is associated with suboptimal exposure of target vessels other than the left anterior descending artery, surgical complexity, and prolonged operating time [17]. The program of robotic cardiac surgery was initiated in 2021 at our department. We report our short and mid-term results with 240 consecutive cases operated with robotic-assisted minimally invasive coronary revascularisation. The vast majority of our series were multivessel CABG cases. The mean number of revascularised vessels was 2.84 in RA-CABG group. Our study provides a comprehensive comparison of multivessel RA-CABG with traditional CS-CABG, presenting findings regarding its potential benefits. Because there was a legitimate suspicion that “low-risk” patients would be assigned to the RA group, we performed propensity score matching using a wide range of preoperative characteristics and selected the most appropriate match from both consecutive cohorts for comparison. In many cases using CPB support with peripheral cannulation (mostly femoral artery and vein) with no related complications, we were able to reach all target vessels with 6–7 cm skin incisions without performing sternotomy or cutting any bone structure, and we achieved complete revascularization in all our cases. There was no need for the use of any further hybrid revascularisation techniques as all target vessels were surgically revascularised. In minimally invasive multivessel coronary bypass surgery, we believe peripheral bypass support is a simple and effective way to gain access of the ascending aorta and vessels in the non-left anterior descending artery territories while maintaining hemodynamic stability. When discussing the advantages of robotic surgery, we should primarily focus on avoiding sternotomy. Consequently, we see that it may reduces risks such as sternal dehiscence, sternal pain, wound infections, prolonged postoperative recovery time, and increased rates of mediastinitis [18–20]. Similar to other reported publications, in our series, mechanical ventilation durations and patients requiring prolonged ventilation (> 24 h) were less common in those undergoing robotic-assisted CABG [21, 22]. Consequently, ventilator-associated complications, intensive care unit stays, and hospital stays were reduced compared to the CS-CABG group. The reporting of successful clinical outcomes and mortality rates comparable to those of sternotomy suggests that the robotic CABG technique may be comparable in safety and effectiveness to conventional methods. When we review the literature, we see that our perioperative and mid-term mortality results are consistent with those reported by experienced centers (below 1%) [14, 17, 23–25]. In our series, we observed less blood loss in the RA-CABG group and, consequently, less use of blood products. We believe this is related to the absence of sternotomy, the use of smaller incisions, and improved comfort and detailed visualization during LIMA harvesting and subsequent bleeding control of the bed. These were generally low and comparable to the outcomes reported by others [14, 23, 26]. CPB times and cross clamp times were shorter in the CS group in our study. As mentioned earlier, we believe that the learning curve in the RA group contributed to this. We observed shorter times in the last 100 cases in the RA group. For the successful implementation of robotic-assisted CABG surgery, it is crucial to have a well-coordinated team consisting of the surgeon, anesthesiologist, nurse, and perfusionist [24]. Other studies on the learning curve in robotic CABG surgery have also shown that safer and more stable clinical outcomes are achieved after reaching a certain number of surgeries [27, 28]. Atrial fibrillation is a common postoperative complication occurring in almost one in three of cardiac surgery operations and prolongs hospital stays and increases morbidity; reducing this is clinically important [29]. In our study, we observed that postoperative AF rates in the RA group were significantly lower compared to the CS group. We think this situation may be related to factors such as less postoperative pain, less frequent anemia, less need for blood transfusions, and fewer infectious conditions. Additionally, in Yokoyama and colleagues’ study of 7330 patients who underwent robotic CABG and were analyzed after propensity score matching, similar to our study, acute kidney injury, length of hospital stay, postoperative hemorrhage, and blood transfusion were higher for nonrobotic CABG compared to robotic CABG [30]. We believe that, in order for robotic coronary artery bypass grafting to be considered equivalent to sternotomy, which is accepted as the gold standard, and to be more widely adopted, it is crucial to report not only the long-term clinical outcomes but also the long-term angiographic outcomes. which were unavailable in this retrospective study. When reviewing the literature, we see publications reporting successful angiographic outcomes in patients who underwent robotic CABG [23, 31]. To briefly evaluate the issue from the patient’s perspective, we are facing an increasingly broad topic. In recent years, parallel to the increasing interest of patients in minimally invasive approaches to robotic-assisted CABG surgery, we have observed a rise in their knowledge of this technique and a significant increase in their demand for robotic surgery among treatment options. This trend, coupled with the prominence of patient-centered expectations such as smaller incisions, faster recovery times, and cosmetic advantages, is leading to robot-assisted approaches being considered more frequently in the surgical decision-making process. Furthermore, we believe that the widespread availability of digital information resources and the sharing of experiences between centers contribute to patients’ more informed questioning of treatment alternatives and their active inclination towards minimally invasive robotic revascularization options. However, as surgeons who determine the indication and perform the surgery, the most important issue we focus on when deciding which method to choose, as we have previously stated, is ensuring complete revascularization. Study Limitations Our study has several limitations inherent to its retrospective design and single centre experience with a single group of operating surgeons. The absence of randomization and the potential for selection bias could affect the generalizability of the findings. Despite our maximum effort toward the adjustment of preoperative valuables with propensity-score matching, unmeasured confounders can exist or it is associated with an inherent risk of bias, as for the preoperative patient selection, as for the post-operative patient care. Another limitation is that, due to the lack of Transit Time Flow Measurement (TTFM) capabilities at our hospital, we are unable to assess the condition of the grafts during surgery. Despite these limitations, this study provides valuable insights into the outcomes and feasibility of multivessel robotic MIDCAB. This is essentially a feasibility study exploring the safety and potential advantages of RA-CABG compared to conventional approaches, which still remain the gold standard. The study does not include the long-term outcomes, which we plan to present long-term follow-up in subsequent studies. Conclusions The RA-CABG is a feasible alternative to the conventional sternotomy CABG. This method offers advantages such as avoiding sternotomy, providing greater comfort to the surgeon during LIMA harvesting, and enabling longer LIMA harvesting. Robotic-assisted CABG can be performed safely with favorable short and mid-term results and complete target vessel revascularisation can be achieved with this technique also in multivessel diseases. While the need for randomized prospective studies and more publication of long-term results is evident, as minimally invasive techniques and robotic technology continue to advance and surgical experience increases, it is anticipated that the RA-CABG technique will become an increasingly important option in the surgical treatment of multivessel coronary artery disease. Acknowledgements None. Abbreviations Coronary artery bypass grafting Cardiopulmonary bypass Left internal mammary artery Left anterior descending artery Minimally invasive direct coronary artery bypass Computed tomography angiography Transesophageal echocardiography Percutaneous coronary intervention Intercostal space Author contributions AK, UC, AY, YD, MK, HAS, MFA analyzed and interpreted the patient data. AY performed the literature review and was a major contributor in writing the manuscript. SB performed the final editing of the manuscript. All authors read and approved the final manuscript.AY and AK should be considered co-first authors in this article. Funding This research received no external funding. Data availability The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request. Declarations Ethics approval and consent to participate This study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki. The study protocol was reviewed and approved by İzmir Katip Celebi Health Research Institutional Review Board (no: 0528, date: 11/09/2025). Patient confidentiality and data protection were strictly adhered to during data collection and analysis. An informed consent form was waived due to the study’s retrospective nature and the minimal risk involved. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Arzum Kale and Alizamin Yusifli should be considered co-first authors in this article. References Associated Data Data Availability Statement The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.